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 This study assessed the effects both DTT and progesterone have on bovine 
spermatozoa to induce decondensation or the acrosome reaction in order to facilitate 
male pronuclear formation after ICSI. Sperm prepared by swim-up in a 5 mM 
concentration of DTT displayed time dependent morphological changes resulting in 
decondensation over a 6-hour period. An estimated 90% of treated sperm displayed 
early changes in morphology after the second hour of incubation. Sperm displaying 
partial decondensation of the nucleus was estimated as 42% by the 3rd hour and 
increased to 62% by the 5th hour of incubation. Fully decondensed sperm or sperm with 
completely dispersed DNA increased from 20% at hour 5 to 50% at hour 7. No such 
changes were seen in sperm not treated with DTT (p < 0.01).  Progesterone was used 
to induce an acrosome reaction in sperm which were first capacitated with heparin (10 
µg/mL) prior to treatment with progesterone (10 µM). The acrosome reacting population 
was measured using a conjugated FITC-PNA stain and observations using fluorescent 
microscopy and cytometric flow analysis. Sperm undergoing an acrosome reaction at 
hour 1 was 80.2% and increased to 89.3% after 2 hours. Sperm that completed the 
acrosome reaction increased from 49.8% at hour 1 and 62.5% at hour 2. Only 14.2% 
completed acrosome reactions in sperm not treated with progesterone (p < 0.05).  Using 
these observations with DTT and progesterone treated sperm, ICSI was performed with 
both treatments to assess if rates of male pronuclei formation and successful 
fertilization could be improved. Injection of sperm treated with DTT resulted in 28.3% of 
embryos with 2 pronuclei (2PN) after activation and 16 hours of culture, compared to 
6% in control injections (p < 0.001). ICSI with progesterone treated sperm also resulted 
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in a higher number of 2PN embryos, with 38.1% compared to 10.1% in control injections 
(p < 0.001). These results show that both DTT and progesterone have effects on sperm 
which allow for higher rates of male pronuclear formation after ICSI by utilizing either 























Intracytoplasmic sperm injection (ICSI) has been a valuable tool in many species 
for its ability to not only overcome male factor infertility problems, but also to eliminate 
the risk of polyspermy commonly seen with in vitro fertilization (IVF), and can assist in 
implementing other technologies (Catt et al., 1995). For species with limited gamete 
availability ICSI has the potential of bypassing the need to optimize IVF conditions. 
However, bovine ICSI lacks the success rates that has been observed in other 
mammals (Águila et al., 2017). For example, in humans (Tesarik, 1998) and mice 
(Kimura et al., 1995) the injection of a spermatozoon directly into the cytoplasm of the 
oocyte is sufficient for activation and to initiate decondensation and formation of the 
sperm’s nucleus into the male pronucleus to join with the female genome to complete a 
diploid embryo. This is not the case for bovine ICSI, where injection of a spermatozoon 
is not sufficient for activation or sperm decondensation (Ock et al., 2003). While the 
exact reason has yet to be elucidated, it is suspected to be a combination of both 
oocyte and sperm factors. It has been shown that in vitro matured bovine oocytes may 
be deficient in glutathione, an essential antioxidant which plays a major role in sperm 
decondensation, giving the oocytes a reduced capacity to form a male pronucleus 
(Curnow et al., 2010). This is coupled with bovine sperm’s resistance to 
decondensation, as there is a greater stability of the sperm nucleus due to a high 
density of protamine disulfide bonds and tightly packed nuclear structure compared to 
other species (Hutchison et al., 2017). Despite these challenges, ICSI has the potential 
to be a valuable tool in cattle reproduction. ICSI provides some advantages over IVF in 
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using genetic material more conservatively, as well as being able to improve male factor 
infertility. However, a more valuable application is perhaps in implementing genetic 
editing, CRISPR/Cas9, more efficiently and studying aspects of fertilization. Improving 
on this technology in cattle may also provide insight into improving ICSI for other 




















2.1. Intracytoplasmic Sperm Injection 
The process of successfully combining mammalian oocytes and sperm in vitro to 
create a viable embryo first began with rabbits in the 1950’s, which initiated a decades 
long cascade in reproductive studies (Chang et al. 1959). As the techniques of in vitro 
fertilization (IVF) became more efficient, this allowed for further application in a number 
species, including bovine, to increase propagation of valuable genetics, assist with 
infertility, and implement other genetic technologies. (Ferre et al., 2019). However, IVF 
is not ideal for species prone to polyspermic fertilization, such as porcine, or for 
individuals with low sperm count or motility (Nakai et al., 2014; Simopoulou et al., 2016). 
In such cases, intracytoplasmic sperm injection (ICSI) has been a valuable tool for its 
ability to not only overcome male factor infertility, but also to eliminate the risk of 
polyspermy, or multiple sperm fertilizing a single oocyte (Catt et al., 1995; Salamone et 
al., 2017).  ICSI could also be useful for species where optimization of IVF may not be 
practical because of scarcity of gametes.  
ICSI is the process by which a single spermatozoon is isolated and immobilized, 
by a kinking of the tail, before injecting it directly in to a mature oocyte with the polar 
body centered along the longitudinal axis to avoid disrupting crucial structures, such as 
the spindles and metaphase plate (Simopoulou et al., 2016; Rader et al., 2016). The 
kinking of the tail at the midpiece of the sperm before injection serves not only to 
immobilize the sperm and prevent movement after injection, but it also serves to initially 
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break the spermatozoa’s outer membranes (Simopoulou et al., 2016). The breaking of 
these membranes before injection has been shown to allow for greater frequency of 
fertilization after ICSI by allowing maternal access to the spermatozoa and the release 
of sperm factors for oocyte activation (Salamone et al., 2017). However, in bovine ICSI 
the kinking or disrupting of the midpiece or tail alone is not sufficient as it is in other 
species for fertilization or oocyte activation (Horiuchi and Numabe 1999). Compared to 
traditional IVF, where millions of sperm are needed for fertilization, ICSI is a more 
conservative approach in utilizing genetics, which is ideal if the semen is costly or is a 
limited resource, as is the case in male factor infertility as well as with sexed or 
genetically altered sperm, or in dead or endangered animals (Salamone et al., 2017). 
Since only one spermatozoon per injected oocyte is needed, each unit of frozen semen 
can be sectioned into multiple ‘ICSI-cuts’. Up to ten ‘ICSI-cuts’ can be obtained from a 
single straw of frozen semen that can be thawed separately for its use in separate ICSI 
procedures (Rader et al., 2016). Additionally, some authors maximize the use of 
valuable semen not only by using this strategy, but also by diluting and refreezing the 
semen into smaller quantities, for example, when a frozen semen store is limited or 
when expensive sex-sorted sperm straws are employed (Hamano et al., 1999; Rader 
et al., 2016; Canel et al., 2017). Semen from deceased animals can also be collected in 
emergency situations, by collecting immature sperm from the testicles or epididymis 
post-mortem (Salamone et al., 2017). As these sperm are not yet mature and have 
reduced motility, ICSI is a crucial methodology for utilizing and fertilizing with these 
sperm. This technique is also applicable in the case of azoospermia, or the condition in 
which no sperm are present in an ejaculate (Zheng et al., 2015). Sperm can be 
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harvested from the testicles to treat severe male infertility and used to fertilize an oocyte 
via ICSI (Zheng et al., 2015). In many species, including the rabbit (Hosoi and Iritani 
1993), mouse (Kimura & Yanagimachi 1995), sheep (Catt et al., 1996), horse (Cochran 
et al., 1998), domestic cats (Pope et al., 1998), pigs (Kolbe and Holtz 2000), goats 
(Wang et al., 2003) and humans, ICSI is successful and has resulted in births of live 
offspring (Horiuchi and Numabe 1999; Salamone et al., 2017). However, bovine ICSI 
lacks the success rates that has been observed in other mammals (Goto et al., 1990; 
Águila et al., 2017). Interestingly, conventional bovine IVF, can achieve high success 
rates, leading to cleavage rates over 80%, blastocyst rates of over 40%, and pregnancy 
rates of transferred in vitro produced embryos of approximately 50%, depending on 
methodology (Ferre et al., 2019; Sanches et al., 2017). Bovine ICSI utilizing the same 
general procedures as with other species, generally results in blastocyst rates of less 
than 10% (Goto et al., 1990; Chung et al., 2000; Devito et al., 2010; Arias et al., 2014). 
The great improvements in bovine IVF, and the inferior results observed with bovine 
ICSI emphasize the importance of re-examining the possible causes of these 
differences and highlights the need to study early fertilization events (Salomone et al., 
2017). For reasons not completely known, the injection of a bovine spermatozoa into a 
fully matured bovine oocyte does not commonly result in fertilization or activation of the 
oocyte as it does in some other species. The lack of oocyte activation after sperm 
injection confirms incomplete fertilization after bovine ICSI, in contrast to humans 
(Tesarik, 1998) and mice (Kimura et al., 1995) where the injection of a spermatozoon 
directly into the cytoplasm of the oocyte is sufficient for activation and to initiate 
decondensation and formation of the male pronucleus which joins with the female 
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genome to form a diploid embryo. Thus, after bovine ICSI, activation protocols must 
also be used for pronuclei formation and cleavage to occur to complete fertilization, 
despite this process readily occurring after injection in other species. The addition of 
activation protocols in bovine ICSI further complicates this technology with many studies 
claiming vast differences between protocols and reagents with results varying between 
labs and studies (Ock et al., 2003; Salamone et al., 2017; Suttner et al., 2000). Despite 
great efforts from numerous researchers, it is not known why bovine ICSI remains 
insufficient while IVF is successful (Salamone, 2017; Ock et al., 2003). As most 
processes occurring during fertilization and early embryogenesis are largely ubiquitous 
among most domestic animals, it is suspected that a key process lacking in bovine ICSI 
may shed light in improving other IVF/ICSI protocols. While IVF, in bovine, currently has 
the most commercial potential with high success rates, lower cost, and limited training 
requirements, increasing the efficiency of bovine ICSI could improve the implementation 
of genomic editing technologies (Ma et al., 2017). Currently, the most frequently used 
method to induce genomic editing in bovine oocytes, the CRISPER/cas9 system, is to 
first preform IVF and then subject the zygotes to microinjection at the pronuclear stage 
(Ma et al., 2017). However, this can result in mosaicism, or incomplete integration of 
these constructs into the embryos, and increases the overall handling and stress on the 
embryo (Ma et al., 2017). It has been shown, in humans, that earlier introduction of 
these gene editing constructs, at fertilization with ICSI, reduces the frequency of 
mosaicism and allows for better integration and higher efficiency, as well as reduces the 
total manipulations and handling of the embryos (Ma et al., 2017). While ICSI may not 
have an immediate commercial application for cattle, as it does in humans and horses, 
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the technology has potential value in exploring the mechanisms of fertilization, as well 
as for certain individuals where the sperm is a limited resource, and for implementation 
of genomic editing technologies.  
2.2. Bovine ICSI Pitfalls and Limitations 
Technical Issues 
In addition to physiological constraints with bovine ICSI, there are also physical 
obstacles which make ICSI more difficult in bovine than in other species. Due to the 
high lipid content and presence of vacuoles, bovine oocytes appear much darker 
compared to that of mice or human. As a result, the actual injection process in bovine 
ICSI is blind, or obscured from view, making confirmation of sperm injection extremely 
difficult (Horiuchi and Numabe, 1999). While centrifugation can be used to localize 
these lipids and vacuoles to the periphery of the oocyte to allow for a clear injection 
field, centrifugation of oocytes has been shown to prematurely activate oocytes and 
cause extrusion of the second polar body prior to sperm injection in humans (Tatham et 
al., 1996). Another pitfall to this technique is that bovine spermatozoa are generally 
larger than that of other mammals and requires a larger injection pipette of 8-10 microns 
versus 4-5 microns typically used in human or mouse ICSI (Salisbury et al., 1978). The 
increase in pore size brought about by a larger injection pipette causes more damage 
that the oocyte must recover from (Horiuchi and Numabe 1999). Additionally, bovine 
oocytes have a highly elastic plasma membrane which requires forceful and vigorous 
aspiration of the cytoplasm to fully puncture (Horiuchi and Numabe 1999). With the 
difficulty in puncturing the oocyte, combined with the obstacle of visualizing the injection 
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within the oocyte itself, and the lack of success after ICSI, training of personnel for ICSI 
in bovine oocytes is troublesome, despite bovine oocytes being readily available.  
Physiological Constraints 
While the exact reasons for the lack of success in bovine ICSI has yet to be 
elucidated, it is suspected to be a combination of both oocyte and sperm factors. It has 
been shown that in vitro matured bovine oocytes may be deficient in glutathione, an 
essential antioxidant which plays a major role in sperm decondensation. This gives the 
in vitro matured oocytes a reduced capacity to form a male pronucleus (Curnow et al., 
2010). For most species where ICSI is highly successful, the oocytes are first matured 
in vivo and then collected, fertilized by ICSI, and cultured in vitro. However, due to the 
difficulty of obtaining in vivo matured bovine oocytes, virtually all oocytes used for 
bovine ICSI and IVF are in vitro matured. Incomplete cytoplasmic maturation for in vitro 
matured oocytes compared to the in vivo matured oocyte could result in reduced 
developmental potential of the oocyte before fertilization occurs (Gomez et al., 2000). 
The overall glutathione deficiency in in vitro matured bovine oocytes reflect incomplete 
cytoplasmic maturation and is one difference between ICSI with bovine oocytes versus 
that of human or mouse. This may partially explain the bovine oocytes decreased ability 
to decondense the sperm head, as it is unable to compensate with the increased 
antioxidant demand with ICSI. During IVF, the sperm’s membranes are disrupted and 
weakened in the presence of cumulus cells and contact with the zona pellucida before 
integration into the oocyte. However, this does not occur during ICSI, and thus places a 
greater burden on the oocyte to reduce and decondense the sperm membranes. It has 
been observed that the injection of a bovine spermatozoa into an equine oocyte results 
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in the decondensation of the sperm head and formation of the male pronucleus (Li et 
al., 2003). These details implicate an oocyte factor in the limited success rates of bovine 
ICSI. However, this is also coupled with bovine sperm’s extreme resistance to 
decondensation. In bovine spermatozoa, there is a greater stability of the plasma 
membranes due to a high density of protamine disulfide bonds present, which are also 
accompanied by a more tightly compacted nuclear structure compared to other species 
(Hutchison et al., 2017). This prevents male pronuclear formation and activation of the 
oocyte post-ICSI For male pronuclear formation to occur, the sperm must undergo a 
necessary change which includes the removal of sperm-specific protamines from the 
sperm’s nucleus. These protamines, held together by disulfide bonds, are responsible 
for maintaining the condensed inert state of the paternal genome. Upon removal, this 
process is followed by decondesation of the paternal chromatin and leads to an 
essential replacement of the paternal protamines for maternal histones, which then 
remodel and reassemble the chromatin into a male pronucleus (McLay and Clark, 
2003). The protamine-disulfide bonds which hold the protamines intact are normally 
broken, or reduced, by glutathione within the oocyte during fertilization, following 
permeabilization from the vesiculation of the acrosome reaction. This would normally 
allow for nuclear decondensation and subsequent development. However, the 
persistence of the acrosome or its’ substructures over the anterior part of the injected 
sperm inhibits the exchange with the maternal nuclear proteins during sperm 
decondensation and causes insufficient sperm head decondensation (Sutovsky et al., 
1997; Galli et al., 2003). As ICSI bypasses these critical processes with injection of the 
sperm directly into the cytoplasm of the oocyte, combined with a deficiency in 
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glutathione in in vitro matured bovine oocytes, additional mechanisms are necessary for 
successful fertilization, activation, and pronuclei formation to occur with ICSI in cattle.  
While calves have been born using this technology, it still remains a highly 
inefficient and inconsistent technology (Solermo et al., 2017). The most common 
measure taken to assist bovine ICSI is pre-treating the sperm, prior to ICSI, to assist in 
decondensation. However, the exact physiological sequential processes the sperm 
requires before and during fertilization are not entirely known. If these processes could 
be replicated or simulated in vitro, then bovine fertilization and blastocyst rates by ICSI 
could potentially mirror those seen with traditional IVF. However, currently even with a 
pretreatment of the sperm, which could allow for decondensation, additional measures 
are still required to activate bovine oocytes for fertilization, the resumption of meiosis, 
and further development to occur (Salamone et al., 2017). With IVF or other methods 
where fertilization occurs, as the sperm fuses with the oocyte, sperm factor 
phospholipase C zeta (PLCz) is released and begins the process of oocyte activation. 
PLCz catalyzes the hydrolysis of phosphatidyl 4,5-bisphosphate (PIP2), producing 
inositol-triphosphate (IP3) and 1,2-diacylglycerol (DAG). The increase in 
IP3 concentration is responsible for inducing calcium release from the endoplasmic 
reticulum (ER), the calcium store of the cell, and cause a cyclical rise in calcium which 
signals cyclin B and the proteasomes to decrease protein synthesis of maturation 
promoting factor (MPF). The decline of MPF in response to calcium oscillations results 
in a continuation of the cell cycle and allows for further development. In bovine oocytes, 
the sperm decondensing in response to treatment after injection, or the ICSI procedure 
alone, is not sufficient to activate the oocytes as it is in other species. In humans and 
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mice for example, a sham injection alone or simple insertion of an injection pipette into 
the oocyte can result in rise in calcium leading to activation and subsequent cleavage 
even without the presence of sperm (Dozortsev et al., 1995). In porcine ICSI, a sham 
injection is not as successful for oocyte activation as in humans, but the injection of a 
sperm is sufficient for both fertilization and activation, as it is in humans, mice, and 
horses as well (Catt et al., 1995). It is not clear why this is not the case in bovine 
oocytes, but various chemical methods for activation have been found to be successful 
after ICSI to result in a viable embryo. These methods using various concentrations, 
combinations, and exposure times to chemicals such as calcium ionophores like 
ionomycin, protein inhibitors such as cycloheximide or 6-dimethylaminopurine (DMAP), 
as well as ethanol, mimic the initial activation of the oocyte through calcium signaling 
and a time sensitive down regulation of protein synthesis. These 2 signals in succession 
promote progression of the oocyte though the cell cycle from metaphase II to anaphase 
and the first cell cleavage (Ock et al., 2003). Currently, fertilization of bovine oocytes via 
ICSI is dependent on such activation protocols. Most fertilization that occurs with bovine 
oocytes though natural conception or conventional IVF immediately results in oocyte 
activation and further development without additional treatment, as does ICSI in most 
other species. Yet in cattle, a crucial event of fertilization is missing during ICSI to result 
in complete fertilization. Furthermore, subjecting ICSI oocytes to these activation 
protocols also increases the occurrence of parthenogenic activation, or activation of 
only the maternal genome without incorporation of the male genome, as well as DNA 
fragmentation (Szczygiel and Ward 2002). These parthenogenetically activated oocytes 
can develop beyond the 2-cell stage and potentially up to the blastocyst stage, yet these 
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embryos lack the diploid nature of a viable embryo and only contain one set of 
chromosomes, making these embryos haploid and nonviable. Despite having a sperm 
injected, if the sperm does not decondense these embryos are not fertilized, yet 
morphologically resemble embryos that are successfully fertilized. The presence of 
parthenotes among true fertilized embryos may misconstrue true fertilization, cleavage, 
and blastocyst rates in studies and needs to be accounted for when examining embryo 
development after ICSI with activation to ensure the diploid nature of a viable 
successfully fertilized embryo. Moreover, the use of these activation protocols has been 
shown to produce high numbers of ICSI and parthenote embryos with chromosomal 
abnormalities (De La Fuente and King, 1998; Rho et al., 1998; Ross et al., 2008; Canel 
et al., 2010), explaining in part the low blastocyst rates and frequent pregnancy loss of 
transferred embryos after ICSI. Some argue that with proper treatment of the sperm 
prior to ICSI, oocyte activation should not be needed due to a more complete 
fertilization event occurring, similar to that in IVF (Salamone et al., 2017). However, 
without knowledge of the missing factor in bovine ICSI, treatments will continue to be 
explored to attempt in realizing the potential of this technology.  
There has been a multitude of studies attempting to mimic the effects of 
capacitation, the acrosome reaction, and fertilization in order to improve bovine ICSI yet 
success is still limited, and results remain controversial (Salamone et al., 2017). Studies 
have been done using various sperm pretreatments, such as heparin with 
lysophosphatidylcholine to induce capacitation and the acrosome reaction (Gómez-
Martínez et al., 2019), glutathione to mimic the oocytes natural reducing capacity (Lee 
2015, Canel et al., 2017), various calcium ionophores to signal fertilization events within 
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the sperm (Jamil et al., 1981), and a multitude of other treatments in order to increase 
fertilization rates of bovine ICSI with limited success. One of the most successful 
methodologies initially discovered was the pretreatment of sperm with dithiothreitol 
(DTT), which was reported to lead to an increase in diploid blastocyst rates (Rho et al., 
1998; Galli et al., 2003; Oikawa et al., 2016). However, DTT and other oxidizing and 
reducing compounds may increase the instances of DNA damage or fragmentation 
leading to poly- or mixoploidy embryos, or embryos with chromosomal abnormalities 
(Rho et al., 1998; Suttirojpattana et al., 2016). This, and the lack of any reported live 
births of DTT treated ICSI, highlights an importance to pursue treatments options which 
resemble physiological events to follow natural endogenous pathways for both the 
sperm and the oocyte to increase embryo viability and resemble in vivo conditions more 
closely. As mentioned previously, treatment options such as glutathione have been 
used to treat the sperm before injection. This treatment has been reported to increase 
blastocyst rates compared to DTT treated sperm (Lee et al., 2015). However, the diploid 
nature of these blastocysts was not evaluated and only marginal improvement was 
observed. Another study evaluating glutathione treatment of sperm in bovine ICSI also 
showed increases in blastocyst rates up to 20% however only approximately 62% of 
those had evidence of sperm decondensation (Canel et al., 2017). There remains a 
need for a treatment, or multiple treatments, which simulate the physiological processes 
of fertilization for the sperm in order to achieve consistent decondensation after injection 





2.3. Sperm Treatments for Bovine ICSI 
Membrane Disruptors 
Dithiothreitol (DTT) has been used as a reducing agent and as a pretreatment for 
sperm to reduce the protamine disulfide bonds located in the outer membrane (Galli et 
al., 2003). The complete chemical reduction of these bonds ultimately leads to the 
physical relaxation of the sperm chromatin structure and degradation of the outer 
membranes containing the nucleus, allowing for the maternal histones to access the 
male genome (Rho et al., 1998). This physical change in the chromatin structure 
brought about by DTT, have been shown to increase efficiency of bovine ICSI and rates 
of male pronuclei formation (Suttner et al. 2000, Rho et al., 1998; Galli et al., 2003) 
While results with DTT pretreatment also vary depending on method of activation, as 
well as maturation and culture conditions, some studies have shown an increase in 
diploid blastocyst rates to approximately 20% (Oikawa et al., 2016; Rho et al., 1998). 
However, using DTT as a pretreatment of sperm prior to fertilization may not be ideal 
and result in damage to the sperm’s DNA (Sekhavati et al., 2012). DTT in the oxidized 
form has a stable ring structure with an internal disulfide bond. The redox reaction that 
occurs with DTT contains two sequential thiol-disulfide exchange reactions, which 
closes the ring structure, leaving behind a reduced disulfide bond (Ates et al., 2009). 
This reaction is what dissociates the protamine, allowing for decondensation of bovine 
sperm over at least a 4-7-hour period, or the potential replacement of protamine for 
maternal histones after injection. As DTT continues this redox reaction, the morphology 
of the head and midpiece is altered, causing bending or folding of the head at the 
equatorial segment, swollen or bent midpieces, followed by partial to complete 
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decondensation during incubation in sperm-TALP media (Rho et al., 1998). These 
morphological changes indicate a weakening and breaking down of the membranes, 
which then allow for decondensation to take place. However, as DTT has a high 
propensity to complete its’ ring structure, it is therefore liable to undesired side 
reactions. Residues on the sperm can interact with DNA and proteins to prevent or 
reduce other essential disulfide bond formations. Contrastingly, DTT is also an oxidizing 
agent which may damage paternal chromosomes after exposure, as well as potentially 
interfere with the maternal genome and possibly add an additional stressor to the 
already reduced capacity of the in vitro matured bovine oocyte to handle oxidative 
stress after ICSI (Szczygiel and Ward, 2002; Ashibe et al., 2019). It was observed in 
these studies using DTT treated sperm for bovine ICSI, that the developmental capacity 
of the resulting embryos remains limited. This may be due to DTT toxicity and the effect 
of side reactions on essential cellular structures, DNA fragmentation, and damage to the 
paternal chromosomes (Szczygiel and Ward, 2002: Yamauchi et al., 2011). Results in 
these studies with DTT pretreatment also vary depending on method of activation, as 
well as maturation and culture conditions, but overall does increase the percentage of 
oocytes fertilized compared to nontreated sperm (Oikawa et al., 2016; Rho et al., 1998). 
However, these results are still generally not considered an efficient enough option for 
the practical application of bovine ICSI. The use of DTT to forcibly reduce bonds and 
allow for relaxation of chromatin and the nucleus of the sperm head imitates the 
decondensation of the sperm head brought during actual fertilization, yet there are 
many physiological differences in the way these two processes occur. These 
differences may contribute to the limited increase in blastocyst rates seen with DTT 
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treatment and the lack of live births following this sperm treatment. In recent years, 
other membrane-disrupting agents have been tested, such as Triton X-100 (Lee and 
Yang, 2004), sodium hydroxide (Arias et al., 2014), dithiobutylamine (Suttirojpattana 
et al., 2016), lysolecithin (Morozumi et al., 2006; Zambrano et al., 2017) and methyl-β-
cyclodextrin (Arias et al., 2017). Some of these treatments raised blastocyst rates, but 
male pronucleus formation was not improved in all cases and some showed detrimental 
effects to embryo development (Zambrano et al., 2016). While further optimization and 
study of the DTT and other membrane disrupting treatments for bovine ICSI, including 
the timing of injection and observing morphological differences after treatment may help 
improve this technique, another approach would be more beneficial to improving bovine 
ICSI efficiency.  
Physiological Pathway Manipulation  
Another process which can perhaps be more beneficial, yet is not fully explored, 
is utilizing the sperm’s physiological pathways to elicit a similar result as occurs with 
fertilization. Treatments using heparin in addition to lysophosphatidylcholine (LPC) or 
calcium ionophores, such as A23187, have been used to simulate capacitation and the 
acrosome reaction (Parrish et al., 1988). Both LPC and A23187 have been confirmed 
separately to induce the acrosome reaction and resulting vesiculation and fusion of the 
acrosomal membranes and release of acrosomal contents in bovine spermatozoa 
(Parrish et al., 1988). LPC is known as a fusogenic lipid which has been shown to cause 
fusion of the acrosomal membranes similar to the vesiculation process of the acrosome 
reaction (Parrish et al., 1988). The calcium ionophore A23187 has been shown to 
greatly increase calcium influx, signaling downstream pathways within the sperm to 
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initiate the acrosome reaction (Jamil et al., 1981). However, these treatments in 
conjunction with ICSI have not improved blastocyst rates; with blastocyst rates after 
ICSI of sperm treated with LPC or A23187 less than 10% in some studies (Gómez-
Martínez et al., 2019). There are other treatments which activate the sperm’s 
physiological pathways in fertilization that have yet to be evaluated for bovine ICSI. For 
example, Miller et al. (2016), published the signaling pathways governing the membrane 
localized progesterone receptor on the head of the sperm. It has been noted previously, 
that progesterone is present in not only follicular fluid, but in the cumulus cells 
themselves (Romero-Aguirregomezcorta et al., 2019). It was not known that this source 
of progesterone could have an effect on condensed transcriptionally inactive 
spermatozoa. Most steroid hormone receptors, like those for progesterone, are located 
intracellularly, which would not be accessible due to the compact and condensed nature 
of a sperm cell (Lishko et al., 2011, Miller et al., 2016). Sperm have been observed to 
have one of the few known nongenomic external membrane bound progesterone 
receptors (Miller et al., 2016). It has been shown that use of progesterone treatment 
triggers sequential events in the sperm through the binding of progesterone to this 
surface receptor (Calogero et al., 2000). This binding causes significant influx of 
extracellular calcium through the activation of the sperm-specific calcium channel, 
CatSper, which begins an essential cascade needed for both hypermotility and the 
acrosome reaction to occur (Sun et al., 2017). Progesterone, found to be secreted by 
the cumulus cells in bovine oocyte complexes and also present in the follicular fluid 
released after ovulation, plays a role in vivo to remove capacitated sperm from the 
oviductal epithelium and initiate hypermotility (Romero-Aguirregomezcorta et al., 2019). 
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Once capacitated, spermatozoa’s cell surface receptors are able to interact with 
progesterone to immediately initiate a cascade of biochemical events, which result in 
the activation of intracellular pathways to cause an influx of extracellular calcium 
through the sperm-specific Catsper ion channel. The catsper ion channel has also been 
shown to play a crucial role in hyperactivation and motility (Tamburrino et al., 2014). 
Furthermore, the influx in calcium brought about by Catsper depolarizes the outer 
membranes and activates endogenous pathways which result in the dissociation of the 
acrosomal membranes and increase in cellular activity (Sun et al., 2017). This primes 
the sperm for acrosomal exocytosis, or the acrosome reaction, which removes the 
acrosomal and outer membranes of the sperm. This response can be replicated in vitro, 
by exposing sperm to progesterone to induce the acrosome reaction in bovine sperm 
(Calogero et al., 2000; Contreras et al., 1999). This methodology has been confirmed 
using staining to visualize the exposed acrosomal membranes, using fluorescein 
isothiocyanate-conjugated peanut agglutinin (FITC-PNA). FITC-PNA staining can be 
observed and measured once the plasma membrane is removed through capacitation 
and the acrosomal membranes are exposed. Once exposed, FITC-PNA then selectively 
binds to β-galactose terminals located exclusively within the outer acrosomal 
membrane, indicating an ongoing acrosome reaction (Cheng et al., 1996; Nagy et al., 
2003). This can be used to measure affected sperm, as well as track progression of the 
acrosome reaction after exposure to progesterone. Using progesterone to induce the 
acrosome reaction has been shown to be successful as a pretreatment before ICSI to 
facilitate access to the sperm’s chromatin and allow for increased male pronuclear 
formation (Katayama et al., 2002). As progesterone is known to play a crucial role in 
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vivo, in the bovine female reproductive tract to initiate hyperactivity and the acrosome 
reaction, both crucial for fertilization to occur in vivo, it is suspected that progesterone 
may also assist in vitro (Romero-Aguirregomezcorta et al., 2019). While these steps 
may not be required in vitro with species, such as humans or mice, demonstrated by 
high rates of successful embryo development after ICSI. In cattle and other species with 
low rates of fertilization after ICSI due to failure of the sperm to decondense, induction 
of the acrosome reaction and the subsequent increase in permeability of the outer 
membranes was shown to increase fertilization after ICSI (Tesarik, 1998; Kimura. et al., 
1995). Progesterone as a treatment prior to bovine ICSI may provide a missing key 
difference between fertilization with IVF versus ICSI, as progesterone is present in the 
cumulus cells and influences downstream pathways for fertilization. While this has been 
shown with similar acrosome reaction inducing agents, such as LPC and calcium 
ionophore A23187, these do not utilize a natural endogenous pathway within the sperm, 
but only partially manipulate other signaling pathways to lead to an effect (Gómez-
Martínez. 2019). In human, porcine, and mouse spermatozoa, progesterone has been 
shown to induce an acrosome reaction (Contreras 1999; Katayama et al., 2002; 
Parinaud et al., 1992). It has also been shown that progesterone treatment of mouse 
sperm can increase fertilization rates after sub-zonal sperm injection compared to non-
treated controls, with lower cytotoxic effects than A23187 (Parinaud et al., 1992). 
Similarly, with porcine spermatozoa, progesterone treatment has been shown not only 
to induce vesiculation of the acrosomal membranes consistent with the acrosome 
reaction, but was also shown to increase male pronuclei formation after ICSI to 64% 
compared to 31% for nontreated sperm injection (Katayama et al., 2002). These studies 
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show such treatment should be evaluated in bovine ICSI to see if any improvements in 
efficiency can be made. Eventually, the exact necessary sequential series of events the 
sperm undergoes during fertilization will be discovered. Using bovine ICSI with sperm 
treatments has the potential to help understand which signals are critical for the sperm 

















SPERM DECONDENSATION AND MALE PRONUCLEAR FORMATION 
FOLLOWING BOVINE INTRACYTOPLASMIC SPERM INJECTION 
 
3.1. Introduction 
 Intracytoplasmic sperm injection (ICSI) has been a valuable tool in many species 
for its ability to not only overcome male factor infertility problems, but also to eliminate 
the risk of polyspermy commonly seen with in vitro fertilization (IVF), and can assist in 
implementing other technologies (Catt et al., 1995). For species with limited gamete 
availability, ICSI has the potential of bypassing the need to optimize IVF conditions. It 
has also been shown, in humans, to improve upon current genome editing  
technologies (Ma et al., 2017). However, bovine ICSI lacks the success rates that has 
been observed in other mammals (Águila et al., 2017). There have been both sperm 
and oocyte factors identified to play a part in the lack of success with bovine ICSI, 
including hyper-condensed sperm as well as a glutathione deficiency within in vitro 
matured oocytes. However, the overall lack of sperm decondensation is the limiting 
factor in ICSI success in cattle. Without sperm decondensation, successful fertilization 
post-ICSI is impaired, as the oocyte histones responsible for forming the nuclear 
structure of the male pronucleus cannot bind to transcriptionally inactive chromatin 
present before the sperm undergoes an essential morphological change. This required 
change includes the removal of sperm-specific protamines from the sperm’s nucleus, 
responsible for holding the condensed inert state of the paternal genome. With the 
removal of the protamines, decondesation of the paternal chromatin occurs (McLay and 
Clarke, 2003) This then leads to a replacement of the paternal protamines with maternal 
histones, which remodel and reassemble the chromatin into a transcriptionally active 
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male pronucleus. (McLay and Clark, 2003). The disulfide bonds which hold the 
protamines intact are normally broken, or reduced, by glutathione during these 
processes during fertilization following the acrosome reaction and fusion with the oocyte 
plasma membrane, allowing for nuclear decondensation and subsequent development. 
However, because ICSI bypasses these critical processes with injection of the sperm 
directly into the cytoplasm of the oocyte combined with a deficiency in glutathione in in 
vitro matured bovine oocytes, additional measures must be taken for successful 
fertilization and pronuclei formation to occur. The most common approach is pre-
treating the sperm, prior to ICSI, to assist in decondensation. Dithiothreitol (DTT) has 
been used as a reducing agent and as a pretreatment for sperm to reduce the 
protamine disulfide bonds located in the outer membrane (Galli et al., 2003). The 
complete chemical reduction of these bonds ultimately leads to the physical relaxation 
of the chromatin structure and degradation of the outer membranes containing the 
nucleus, eventually resulting in a decondensation of the sperm DNA (Rho et al., 1998). 
This physical change in the chromatin structure brought about by DTT, has been shown 
to increase efficiency of bovine ICSI and rates of male pronuclei formation (Suttner et 
al., 2000; Rho et al., 1998). However, it was observed in these studies that the 
developmental capacity of the resulting embryos remains limited. There is also a 
concern with DTT toxicity and the effect of residues on formation of essential structures, 
which can result in undesirable side reactions, DNA fragmentation and damage to the 
paternal chromosomes (Szczygiel and Ward. 2002; Yamauchi et al., 2011). Results with 
DTT pretreatment also vary depending on method of activation, as well as maturation 
and culture conditions, but some studies have resulted in approximately a 10-15% 
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diploid blastocyst rate (Oikawa et al., 2016; Rho et al., 1998). Another process, not 
wholly explored, is utilizing the sperm’s physiological pathways to illicit a similar result. 
Using progesterone, part of the natural endogenous pathway of sperm capacitation, 
triggers sequential events in the sperm through the binding of progesterone to surface 
receptors (Calogero et al., 2000). This binding causes an influx of extracellular calcium 
through the activation of the sperm-specific calcium channel, CatSper, which begins an 
essential cascade needed for both hypermotility and the acrosome reaction to occur 
(Sun et al., 2017). Progesterone, secreted by the cumulus cells in bovine oocyte 
complexes and also present in the follicular fluid released after ovulation, plays a role in 
vivo to remove capacitated sperm from the oviductal epithelium and initiate hypermotility 
(Romero-Aguirregomezcorta et al., 2019). This primes the sperm for acrosomal 
exocytosis, or the acrosome reaction, which removes the acrosomal and outer 
membranes of the sperm. This response can be replicated in vitro to induce the 
acrosome reaction in bovine sperm with exposure to progesterone (Calogero et al., 
2000; Contreras et al., 1999). With staining, using fluorescein isothiocyanate-conjugated 
peanut agglutinin (FITC-PNA), this process can be observed and measured once the 
plasma membrane is removed following capacitation. Once removed, FITC-PNA then 
selectively binds to the exposed β-galactose terminals located within the outer 
acrosomal membrane, indicating an ongoing acrosome reaction (Cheng et al., 1996; 
Nagy et al., 2003). This can be used to measure the population of affected sperm, as 
well as track progression of the acrosome reaction after exposure to progesterone. 
Using progesterone to induce the acrosome reaction has been shown, in other species, 
to be successful as a pretreatment before ICSI to facilitate access to the sperm’s 
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chromatin and allow for increased pronuclear formation (Katayama et al., 2002). This 
study aims to measure the effects of both DTT and progesterone on bovine 
spermatozoa in experiments 1 and 2, respectively, after treatment through tracking and 
observation of morphological changes, staining with Hoechst for DTT treated sperm and 
FITC-PNA for progesterone treated sperm, as well as cytometric flow analysis of 
progesterone treated sperm. In experiments 3 and 4, ICSI was performed to evaluate 
DTT and progesterone, respectively, as pretreatment for sperm prior to ICSI in bovine 
oocytes by assessing rates of pronuclear formation 16 hours after fertilization. While 
DTT pretreatment of sperm has been investigated with bovine ICSI, to our knowledge, 
no such studies have been done investigating the effects of progesterone sperm 
pretreatment for bovine ICSI. These experiments will begin to examine these effects to 
further elucidate on critical processes of fertilization and if the efficacy of bovine ICSI 
can be improved in this manner.  
3.2. Materials and Methods  
Chemicals and Reagents 
Unless stated otherwise, all chemicals and reagents were purchased from 
Sigma-Aldrich (St. Louis, MO, USA). 
Oocyte and Semen Allocation 
Oocytes used were abattoir derived and commercially sourced through DeSoto 
Genetics (TN, USA). Semen used was commercially processed Holstein semen 




DTT Treatment and Evaluation  
Frozen semen was thawed by immersion in a 37°C water bath for 30 seconds 
before being washed in 2 mL of non-capacitating media (BO-SemenPrep; IVF scientific) 
by centrifugation for 5 minutes at 400 x g, to remove extenders. A swim-up was then 
prepared and the pellet was layered under 2 mL sperm-TALP (Cassion, Smithfield, TN) 
containing a 5 mM concentration of DTT. Control sperm swim-up was not supplemented 
with DTT. After 1-hour incubation, the top 0.5 mL was removed and washed twice in the 
same non-capacitating medium. Sperm were then cultured in sperm-TALP at 5% CO2 at 
37°C and either diluted for injection or observed hourly for 7 hours under phase contrast 
at 400x to assess the progression of decondensation after exposure to DTT. Changes 
in morphology of DTT treated and non-treated sperm were observed through a 
combination of phase-contrast and Hoffman Modulation Contrast microscopy. To 
confirm DNA dispersal, DTT treated sperm were stained with Hoechst 33342 (1 µg/mL) 
and viewed under fluorescence microscopy. The proportion of sperm affected by DTT 
was estimated by a single observer and categorized into different stages of 
decondensation based on progressive time-dependent changes in morphology. Stage 1 
includes sperm which have a folded head at the equatorial segment, a bend and 
swelling of the mid-piece. Sperm in stage 2 had partial decondensation with pock 
marking and early expansion marked by larger head size (7-9 µm). Followed by stage 3, 
which includes decondensed sperm with a head size of 10 um or greater and sperm 
that had dispersing DNA, which was confirmed as DNA with Hoechst staining This was 




Progesterone Treatment and Evaluation  
Semen was thawed in a 37°C water bath for 30 seconds before separation using 
a discontinuous gradient (Irvine Scientific, Santa Ana, CA) which was centrifuged for 10 
minutes at 400 x g. The pellet was then removed and diluted into a capacitating sperm-
TALP medium containing heparin (10 µg/µl) for 4 hours at a concentration of 1 x 106 
spermatozoa per mL with 5% CO2 and 37°C. Dilutions were calculated after 
spermatozoa counting with a hemocytometer. Once capacitated, sperm were then 
introduced to progesterone (10 µM dissolved in ethanol) for a period of 15 minutes. 
Sperm were then either incubated further for 1 hour to allow for completion of the 
acrosome reaction prior to ICSI, or immediately stained with fluorescein isothiocyanate-
conjugated peanut agglutinin (FITC-PNA (5 µg/mL)) for 15 minutes for analysis through 
flow cytometry (Accuri C6 flow cytometer) as well as fluorescent microscopy. For flow 
cytometry, to observe a larger population, semen from 6 different bulls was used with at 
least 3 repetitions per bull. After thawing, semen was washed by centrifugation and 500 
µl of sperm suspension was placed into a 1.5 mL centrifuge tube to allow for the 
determination of total acrosome reacting population. Progression of the acrosome 
reaction over 2 hours was monitored by observing changes in fluorescence. Pre-
warmed slides were used containing 10 µL of an immobilized sperm suspension in 
mounting media under a cover slip. Loss of a fluorescing acrosome accompanied by a 
reminiscent halo on the sperm head was assumed to be characteristic of a completed 
acrosome reaction. Sperm were also assessed for hypermotility prior to staining by 
aliquoting 10 µL of treated sperm onto prewarmed slides. Samples were then 
randomized and viewed by a single observer, using integrated phase contrast 
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microscopy at a magnification of 200x, to determine percentage of hyperactive sperm 
out of a total 50 motile sperm. This was repeated 3 times for a total of 150 sperm per 
slide, which was done in 3 replicates. Sperm were considered hyperactive if a curved, 
helical, or non-linear trajectory was present, along with highly exaggerated tail 
movements and distinct swimming pattern consistent with other observations of 
hyperactivated motility (Ho et al., 2002).  
Intracytoplasmic Sperm Injection (ICSI) 
Sperm injection was performed at 200x magnification (Nikon TE200) with 
Hoffman Modulated contrast on a heated stage maintained at 37°C. Mature metaphase 
II bovine oocytes were denuded in 1 mg/mL hyaluronidase with vortexing before being 
placed in prewarmed 5 µl droplets of hepes-TALP (Cassion, Smithfield, TN) under 
mineral oil in 50 X 9-mm polystyrene micromanipulation dishes (Falcon; Fisher 
Scientific, Atlanta, GA) for injection. Oocytes with no polar body were not included. 
Sperm were then washed twice in sperm-TALP before the addition of 2 µL of the sperm 
suspension to a 10 µl droplet of 7% PVP (SAGE In Vitro Fertilization Trumbull, CT) also 
in the injection dish. An injection pipette with an inner diameter of 8 µm (Origo 
Charlottesville, VA), connected to Narishige manipulators operated by Eppendorf 
CellTram oil syringe injectors, was used to select and immobilize sperm. Control, or 
untreated sperm, were chosen dependent on morphology and trajectory, while DTT 
treated sperm were selected based on characteristic abnormalities of the head after 
treatment (see Results) (Rho et al., 1998). In the case of progesterone treated sperm, 
selection was based upon presence of hyperactive characteristics, such as a curved 
trajectory with exaggerated and asymmetrical tail movements, as well as a missing or 
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hazy acrosome (see Results) around the acrosomal region of the head consistent with 
signs of an ongoing or completed acrosome reaction (Mortimer et al., 1987). Staining 
was not used for confirmation of sperm’s status during injection due to the possible 
toxicity of the stain. Once immobilized and the tail visibly kinked using the bottom edge 
of the injection pipette, the sperm was aspirated tail first into the injection pipette which 
was then moved into the 5 µl injection drops containing oocytes. Oocytes were 
orientated with the first extruded polar body at the 6 or 12 o’clock position and held with 
negative pressure of a holding pipette with an inner diameter of 30 µm (Origo 
Charlottesville, VA). A single spermatozoon is then brought close to the tip of the 
injection pipette as it was advanced forward into the oocyte. Once firm contact was 
made with the oolema, aspiration was used to break the oolema until free unimpaired 
movement of cytoplasm was seen. The aspirated cytoplasm and the sperm were then 
expelled past the central line of the oocyte. If any excess media was present, it was 
aspirated as the injection pipette was removed from the oocyte. Injected oocytes were 
then removed from the injection dishes and held in hepes-TALP at 37°C before 
activation.  
Oocyte Activation and Evaluation 
Both injected and non-injected oocytes were activated using an Ionomycin/DMAP 
protocol after ICSI. Non-injected oocytes were parthenogenetically activated to serve as 
quality control for each repetition. For activation, oocytes were introduced to 5 µm 
Ionomycin in hepes-TALP with 3 mg/mL BSA for 5 minutes followed by washing in 
hepes-TALP containing 30 mg/mL BSA for an additional 5 minutes, to stop the 
activation process. Oocytes were then washed twice in SOF media (Cassion, 
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Smithfield, TN) before being transferred to drops containing 5 mM DMAP in SOF to be 
cultured for 4 hours. After 4 hours, presumptive zygotes and parthenotes were washed 
and transferred to commercial culture media (BO-IVC IVF scientific) and incubated for 
16 hours under a 6% CO2 atmosphere at 38.5°C. After 18 hours of culture, oocytes 
which had degenerated after injection or were not successfully injected were removed 
and the remaining presumptive zygotes were washed in PBS and stained using 
Hoechst 33342 (1 µg/mL) in calcium and magnesium free PBS (Gibco) and incubated 
for 15 minutes. Presumptive zygotes were then placed on microscope slides (Thermo 
scientific) with excess media removed before 10 µl of gold anti-fade permount 
(Invitrogen) and a coverslip was applied. The slides were then viewed on a Nikon 
H600L at 400x to assess pronuclear formation. Parthenotes were considered activated 
if 1 or 2 pronuclei were present. Injected embryos were considered successfully 
fertilized if 2 pronuclei and 2 polar bodies were present without a sperm head. If a 
sperm head was present, the embryo was considered parthenogenetically activated but 
not successfully fertilized.  
Statistical Analysis  
In experiment 1, the mean estimated proportion of DTT treated sperm in each 
stage of decondensation over hourly time points was analyzed through ANOVA. Results 
from experiment 2 were also analyzed through ANOVA, to determine significance of 
progesterone induced acrosome reactions in treated versus non treated sperm. Flow 
cytometry results using multiple bulls were analyzed for bull variance and normality, and 
the data was determined to be normally distributed prior to ANOVA. All means are 
presented ± SEM. In experiments 3 and 4, differences for frequency of pronuclei 
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development after injection of DTT and progesterone treated sperm, respectively, 
compared to controls were analyzed using Yates’ corrected chi square. Differences 
were considered significant when p < 0.05.  
3.3. Results 
Experiment 1. Effects of DTT Treatment on Sperm Decondensation 
As shown in table 1 and figures 1 and two, treatment with DTT elicits extensive 
progressive time dependent changes in spermatozoa as the outer membranes dissipate 
and allow for the dispersal of chromatin and DNA. Decondensation of sperm were 
separated into 3 different stages as seen in figure 1. These stages are defined by the 
progressive characteristics of decondensing sperm. With stage 1 including early 
characteristics, such as head folding at the equatorial segment or a bend in the mid-
piece. Followed by stage 2 with partial decondensation seen by early expansion, 
marked by larger head size, and obvious pock-marking of the head. Finally, fully 
decondensed sperm heads measuring ≥10 µm in diameter and sperm with DNA 









Table 1. Sperm undergoing decondensation following DTT treatment.  
Time after treatment Percent of Spermatozoa decondensation in Stages 
 Stage 1 Stage 2 Stage 3 
Hour 1 80 ± 3.5   19 ± 6.5 0 ± 0 
Hour 2 88 ± 4.4 * 23 ± 5.7 2 ± 1.4 
Hour 3 44 ± 4.2 42 ± 3.7  7.8 ± 1.8 
Hour 4 29 ± 7.4 51 ± 6.4  19 ± 7.4 
Hour 5 18 ± 5.6 62 ± 8.3 * 42 ± 6.9  
Hour 6 18 ± 7.2 57 ± 9.2 45 ± 9.2  
Hour 7 12 ± 4.1 50 ± 8.8 64 ± 6.4 * 
All values are ± SEM taken over at least 8 repetitions. * denotes significant maximum 
percent in time points for each stage. No such changes were observed in control sperm.  
(p < 0.05) 
 
An estimated 88% of treated sperm displayed early changes in morphology, including a 
bend at the equatorial segment after the second hour of incubation. Sperm displaying 
partial decondensation, in stage 2, was estimated 42% by the third hour and increased 
to 62% 5 hours after treatment. Stage 3 expansion began at hour 3 and increased to 



















Figure 1. Morphological changes seen in spermatozoa following a 5mM treatment of     
DTT for 1 hour. (A) Control spermatozoon with normal morphology under phase-
contrast. (B) Sperm after 1 hour of treatment with head folded at the equatorial 
segment. (C) Sperm at hour 3 displaying pock-marking consistent with partial 
decondensation and a characteristic bend at the mid-piece. (D) Spermatozoa, seen 3 
hours after treatment, beginning to expand. (E) Sperm at hour 5 of incubation with 
continuing decondensation. (F) Fully decondensed nucleus of a spermatozoa 6 hours 
after treatment, approximately 12 µm in diameter. (G) Complete dispersal of the 
chromosomes after hour 7 of incubation. These morphological changes were not seen 
in control sperm. Scale bar is 5 µm. 
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Figure 2. Percent of the population of sperm treated with DTT in separate stages of 
decondensation demonstrating the relationship between stages at differing time points. 
(p < 0.01). 
 
Experiment 2. Effects of Progesterone Treatment on Bovine Spermatozoa 
Sperm were treated with progesterone after heparin capacitation and compared 
to controls with fluorescent microscopy and flow cytometry. Loss of the acrosome 
consistent with the acrosome reaction was measured using FITC-PNA staining, over a 
time period of 2 hours. Beginning with the percent of the population undergoing this 
reaction in the initial 15 minutes after treatment and continuing in 15-minute intervals. 
Hyperactivation was assessed immediately, prior to staining, in both progesterone 
treated and nontreated sperm. In treated sperm, there was a mean of 77.4% (± 6.5) of 
sperm considered hyper-motile, which decreased rapidly with time. In sperm not treated 
with progesterone, an estimated 25.3% (± 4.1) were hyperactive after capacitation alone 
(p < 0.05). 
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Immediately after treatment and staining, sperm were analyzed using flow 
cytometry to determine percentage of the population that had exposed acrosomal 
membranes and had initiated the acrosome reaction. Sperm with no staining were 
analyzed to set a baseline fluoresce level and compared to heparin control and 
progesterone treated sperm.  
Figure 3. Flow cytometry output for progesterone treated and nontreated sperm. (A) 
Forward versus side scatter plot of nontreated sperm to determine region of interest, 
P1. (B) FITC fluorescence seen in FL1 (gated for P1) for non treated and non stained 
sperm, as well as heparin capacitated and heparin and progesterone treated sperm 
stained with FITC-PNA.  
 
By comparing the number of fluorescent sperm in each sample, the mean 
percentage of acrosome reacted sperm after progesterone treatment was found to be 
83.7 (± 6.8), while the percent of acrosome reacted sperm after heparin only was 15 
(±7.5). Showing a significant increase in FITC-PNA fluorescence and induction of the 
acrosome reaction following progesterone treatment (p < 0.05). This was consistent with 
results observed and manually counted by a blind observer under fluorescent 
microscopy. In which the mean percent of progesterone treated sperm which were 
positive for an acrosome reaction at 15 minutes was estimated to be 80.2% (± 4.2) and 
increased to 89.3% (± 3.9) after 2 hours. An observed 49.8 (± 5.1) and 62.5 (± 7.4) 
(A) (B) 
No Staining 
Heparin + FITC-PNA 




percent of sperm had a completed acrosome reaction after 1 and 2 hours of incubation 
after treatment, respectively. A remaining 13% (± 2.7) of sperm were unaffected by 
treatment with no visible staining. In controls, sperm treated only with heparin had 
28.9% (± 8.3) of sperm automatically acrosome react, which did not significantly 
increase with time and an estimated 14.2% (± 3.6) had a completed acrosome reaction 







Figure 4. (A) FITC-PNA binding to the exposed acrosome 15 minutes after 
progesterone treatment under DIC microscopy. This was considered positive for an 
acrosome reaction. (B) Without fluorescence, a distorted acrosome can be seen as a 
haziness and lack of definition around the front edge of the head at 200-400x. (C) 
Indenting around the equatorial segment and a narrower head consistent with loss of 
acrosomal membranes, which is confirmed with FITC-PNA. (D) Staining remains only 
around binding regions of the acrosomal membranes creating a halo, which is indicative 
of a completed acrosome reaction and loss of acrosomal membranes. 
 
 
Experiment 3. Use of DTT Sperm Treatment for Bovine ICSI 
Semen treated with DTT as well as nontreated sperm were used for injection into 
mature metaphase II bovine oocytes. Oocytes were activated after injection and then 
cultured for 16 hours before cytological observations were made. Oocytes which were 
injected and developed 2 pronuclei and no visible sperm head were considered to be 
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successfully fertilized. Table 2 shows the rates of fertilization, as well as activation. 
Oocytes were considered activated, but not fertilized, if 1 or 2 pronuclei were present in 
conjunction with a visible sperm head. Based on these criteria, the proportion of oocytes 
successfully fertilized with DTT treated sperm (42 of 148: 28.3%) was significantly 
higher than controls (11 of 117: 9%), despite activation rates being significantly lower 
than both control injection and those parthenogenetically activated (82 out of 148: 
55.4% vs. 84 of 117: 71.8% vs. 72 of 94 :76.5%; p < 0.001). In both injection groups, a 
proportion of oocytes remained at metaphase II with an intact sperm head present. 
There was no significant difference found between the DTT treated group which 
contained 24 of 148 (16.2%) and the control group that contained 22 of 117 (18.8%) of 
injected oocytes which did not activate. Cytological observations were also made to 
assess DNA fragmentation, seen as abnormalities in pronuclear structure and a 
scattering of visible DNA after staining. While differences in visible fragmentation were 
not significant between parthenote and control groups (13.8% vs 15.7%), the DTT 









Table 2. Effect of DTT treatment of sperm on fertilization rates of injected bovine 
oocytes 
Table 2. Differences in both fertilization and activation between ICSI with control and 
DTT treated sperm were found to be significant (p < 0.001). Oocytes were considered 
fertilized if they contained 2 pronuclei and no visible sperm, while oocytes which were 
considered activated had 1 or 2 PN with sperm or were parthenogenetically activated 
and not fertilized. DNA fragmentation was assessed in zygotes containing at least 1 
pronuclei.  
 
Experiment 4. Use of Progesterone Treatment of Sperm for Bovine ICSI 
Sperm which were capacitated over a 4-hour period with heparin and treated, or 
not, with progesterone for 1 hour were used for injection into metaphase II bovine 
oocytes. Oocytes were then activated, cultured, and stained as described above, before 
pronuclear formation was assessed. The same criteria for activated and fertilized 
oocytes as described in experiment 3 are used for experiment 4 as well. Table 3 shows 
that the rate of fertilization based on these criteria were significantly higher for 
progesterone treated sperm than controls (42 of 110 (38.1%) vs 11 of 109 (10.1%)). 
While both injection groups contained oocytes that remained at metaphase II after 
injection, they did not differ significantly with 11.8% for the progesterone treated group 
and 12.8% for the control group.  








DTT treated sperm 148 82 (55.4%) 42 (28.3%) * 44 (35.4%) * 
Control (no DTT) 117 84 (71.8%) 7 (6%) 15 (15.7%) 
Parthenogenetically 
activated 
94 72 (76.5%) N/A 10 (13.8%) 
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Table 3. Effect of progesterone treatment of sperm on fertilization rates of injected 
bovine oocytes 
Table 3. Differences in fertilization between ICSI with control and Progesterone (P4) 
treated sperm were found to be significant (p < 0.001). Oocytes were considered 
fertilized if they contained 2 pronuclei and no visible sperm, while oocytes which were 
considered activated had 1 or 2 PN with sperm or were parthenogenetically activated 
and not fertilized. Cytological observations were made for DNA fragmentation in zygotes 
containing at least 1 pronuclei and no significant differences were found between 
experimental groups.  
 
Cytological observations were made, in a similar manner to experiment 3. After 
16 hours post ICSI, embryos were stained and assessed. Interestingly, in a portion of 
the activated zygotes containing only 1 pronucleus and a sperm head (8 out of 55 
activated oocytes; 14.5%), an abnormal staining pattern can be seen in the acrosomal  
region of the sperm head with a surrounding halo of stained DNA, seen in figure 5. This 













Heparin + P4 110 55 (50%) 42 (38.1%) * 17 (17.5%) 
Heparin only 109 84 (71.8%) 11 (10.1%) 15 (15%) 
Parthenogenetically 
activated 











Figure 5. Abnormal and normal staining patterns in fertilized zygotes using 
progesterone treated sperm. Shown is two embryos each injected with a sperm treated 
with progesterone. (A) An activated oocyte with 1 pronucleus with a sperm head 
present. Abnormal staining patterns can be seen in the acrosomal region of the head 
surrounded by partial development or indistinct halo of stained DNA, possibly signaling 
on going decondensation or asynchronous fertilization. No such abnormalities were 
seen in sperm not treated with progesterone. Compared to (B), which shows a 2PN 
embryo with 2 polar bodies created with progesterone treated sperm.  
 
3.4. Discussion 
Bovine ICSI is a potentially valuable tool and improvements upon this technique could 
benefit both research and cattle breeding. This study demonstrated the effects brought 
about by both DTT and progesterone treatment of sperm over time, as well as how 
these treatments can affect the efficacy of ICSI in cattle. The hyper-stabilized nature of 
bovine spermatozoa, which is especially resistant to physical and chemical disruption, is 
mostly due to the conversion of protamine sulfhydryl groups to disulfide bonds as the 
spermatozoa passes through the epididymis (Braun, 2001). These bonds, which are 




spermatozoa having a more stabilized chromatin (Perreault et al., 1988). This produces 
a tightly condensed and highly stable nucleus that is resistant to decondensation 
(Hutchison et al., 2017). These features of bovine spermatozoa limit ICSI effectiveness 
in cattle. Seeking treatments which effect the sperm in a similar manner to that of 
fertilization may improve fertilization rates and embryo development following bovine 
ICSI.  
In this study, it was shown that both DTT and progesterone using different 
mechanisms provide access to the male genome, allowing for decondensation and 
fertilization to occur after bovine ICSI. While the two treatments, DTT and progesterone, 
cannot be directly compared in this study, it is shown that both are capable of producing 
successfully fertilized embryos in comparable in vitro settings, with identical activation 
and culture protocols. These results, with some variations due to differences in semen 
preparation, maturation, activation, and culture protocols compare with results of other 
studies (Rho et al., 1998; Galli et al., 2003) However, limited publications could be 
found using progesterone as a pretreatment of bull sperm prior to ICSI. Similar results 
were observed with porcine ICSI (Katayama et al., 2002). This study focused on sperm 
decondensation and pronuclear development to elucidate the early processes of 
fertilization and ICSI in cattle. Further study should be done to assess later embryo 
development potential.  
DTT is known to be a reducing agent, which once oxidized forms a stable ring 
structure with an internal disulfide bond. The redox reaction that occurs contains two 
sequential thiol-disulfide exchange reactions, which closes the ring structure, leaving 
behind a reduced disulfide bond (Ates et al., 2009). This reaction is what dissociates the 
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protamine, allowing for decondensation of bovine sperm, over at least a 4-7-hour 
period, followed by the replacement of protamine with maternal histones after injection. 
As DTT continues this reaction, the morphology of the head and midpiece is altered, 
causing bending or folding of the head at the equatorial segment, swollen or bent 
midpieces, followed by partial to complete decondensation during incubation in sperm-
TALP (Rho et al., 1998). These morphological changes, also seen in this study, indicate 
a weakening and breaking down of the plasma and nuclear membranes, which then 
allow for decondensation. However, DTT has a high propensity to complete its’ ring 
structure and also catalyze undesired reactions with residues interacting with DNA and 
proteins to prevent or reduce other essential disulfide bonds. Contrastingly, DTT is also 
an oxidizing agent which may damage paternal chromosomes after treatment, as well 
as potentially interfere with the maternal genome creating an additional stressor to the 
already reduced capacity of the in vitro matured bovine oocyte to handle oxidative 
stress after ICSI (Szczygiel and Ward. 2002; Ashibe et al., 2019). While further study 
would be needed for verification, this may be the cause of the increased visible DNA 
fragmentation seen in oocytes injected with DTT treated sperm. Despite sperm being 
washed thoroughly after treatment, additional measures may need to fully remove DTT 
residue on the sperm.  
Progesterone is known to play a role in vivo, in the bovine female reproductive 
tract to initiate hyperactivity and the acrosome reaction, both of which are crucial for 
fertilization to occur (Romero-Aguirregomezcorta et al., 2019). These steps may not be 
required in vitro with species, such as humans or mice, where high rates of successful 
embryo development after ICSI have been demonstrated with sperm permeabilized only 
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by a kinking or breaking of the tail at the midpiece (Tesari., 1998; Kimura Y. et al., 
1995). However, in cattle and other species with low rates of fertilization after ICSI due 
to failure of the sperm to decondense, induction of the acrosome reaction and the 
subsequent increase in permeability of the outer membranes was shown to increase 
fertilization after ICSI. This has been shown with similar acrosome reaction inducing 
agents, such as lysophosphatidylcholine (LPC) and calcium ionophore A23187, which 
do not utilize the sperm’s natural endogenous pathway (Gómez-Martínez. 2019). Once 
capacitated, the spermatozoa’s cell surface receptors are able to interact with 
progesterone to immediately initiate a cascade of biochemical events, which result in 
the activation of intracellular pathways to cause an influx of extracellular calcium 
through the sperm-specific Catsper ion channel. Catsper has also been shown to play a 
crucial role in hyperactivation and motility (Tamburrino et al., 2014). Furthermore, the 
influx in calcium brought about by Catsper depolarizes the outer membranes and 
activates endogenous pathways which result in the dissociation of the acrosomal 
membranes and increase in cellular activity (Sun et al., 2017). Conjugated FITC-PNA 
was used to demonstrate this in vitro in this study, as it selectively binds to β-galactose 
sugars present only in the outer acrosomal membrane (Cheng et al., 1996). By 
observing the time at which a significant proportion of stained spermatozoa had a 
completed an acrosome reaction, a 1-hour incubation time after treatment was deemed 
appropriate for injection. Even though 2-hours of incubation after treatment had a 
greater number of completed acrosome reacted sperm, motility was diminished, which 
is why 1-hour was found preferable for ICSI. By simulating physiological events in vitro 
with progesterone, it was shown that increased fertilization rates with ICSI in cattle can 
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be achieved without the toxicity that DTT, other reducing agents or calcium ionophores 
have, all of which have also been used increase success in bovine ICSI (Parinaud et al., 
1992). However, different concentrations of progesterone, injection times, or other 
factors could assist in a more synchronous fertilization, resulting in a greater number of 
oocytes with 2 pronuclei, instead of 1 pronucleus with a potentially decondensing 
sperm. Further study would be needed to confirm if sperm presenting with abnormal 
staining patterns and the DNA distribution seen is actually a decondensing sperm in 
















SUMMARY AND CONCLUSION 
It has been shown that both DTT and progesterone treatments provide access to 
the male genome in bovine sperm by using different mechanisms for physically relaxing 
the chromatin versus physiologically initiating an acrosome reaction, both resulting in 
higher rates of fertilization with ICSI. DTT breaks disulfide bonds located within the 
sperm head to weaken membrane integrity, allowing for the expansion and subsequent 
decondensation of the nucleus. Progesterone, after capacitation with heparin, initiates 
the acrosome reaction, exposing the acrosomal membranes for vesiculation, and 
mimics in vivo physiological processes prior to fertilization. With ICSI, these treatments 
have both been shown, in similar in vitro settings with identical activation and culture 
protocols, to promote sperm decondensation and subsequent pronuclear development 
after injection into bovine oocytes, increasing rates of fertilization. However, oocytes 
injected with progesterone treated sperm experience similar rates of DNA fragmentation 
as controls, whereas oocytes injected with DTT treated sperm have significantly higher 
rates of DNA fragmentation compared to controls. This suggests progesterone may be 
a better treatment option for bovine ICSI and further research should be conducted to 
elucidate the sequential physiological processes the sperm undergo during fertilization 
and early embryo development to form more successful treatments for bovine ICSI to 
more readily reflect results seen with bovine IVF.  
In the first experiment, the effects of 5mM DTT treatment on bovine spermatozoa 
were evaluated. Extensive progressive time dependent changes were seen in response 
to DTT treatment. With sperm going through stages of decondensation until reaching a 
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fully decondensed state, as DTT continues to reduce disulfide bonds within the outer 
membranes allowing for relaxation and expansion of the chromatin and sperm nucleus.  
These stages of decondensation were characterized and observed over a seven-hour 
time period. These results helped determine appropriate incubation times for further 
experiments with ICSI.  
In the second experiment, the effect of heparin capacitation and progesterone 
treatment and its’ ability to induce an acrosome reaction was assessed in bovine 
spermatozoa. Using FITC-PNA to label exposed acrosomes of sperm undergoing an 
acrosome reaction and flow cytometry, it was determined that progesterone has a 
positive effect in inducing an acrosome reaction. As the acrosome reaction is a critical 
process prior to fertilization, it was determined that progesterone may be a viable 
treatment option for bovine ICSI.  
The third experiment evaluated the effect of DTT pretreatment of sperm on 
fertilization rates in bovine ICSI. It was demonstrated that DTT significantly increased 
fertilization rates, or the rate of zygotes with 2 pronuclei and no visible sperm head, 
compared to nontreated sperm. However, cytological observations were made which 
demonstrated the presence of DNA fragmentation. The occurrence of these 
abnormalities in DNA staining was higher in zygotes following injection with DTT treated 
sperm. Possibly signaling a detrimental effect on early embryo development despite 
increased fertilization rates.  
The final experiment studied the effect of progesterone treatment and 
capacitation of bovine sperm on fertilization rates with bovine ICSI. Using results from 
experiment 2, incubation time after treatment and morphology of affected sperm were 
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determined. Using these criteria, ICSI was preformed and fertilization rates were 
evaluated. It was shown that progesterone increased fertilization rates compared to 
controls. However, it was also seen after staining that an additional portion of 1PN 
zygotes which were injected with a progesterone treated sperm was still in the process 
of sperm decondensation and male pronuclear formation. This indicates asynchronous 
fertilization and further study and optimization of this technique may be needed. Yet this 
experiment shows that utilizing the endogenous fertilization pathways of the sperm, 
such as capacitation and progesterone induced acrosome reaction, can increase rates 
of fertilization in bovine ICSI.  
We can conclude that both DTT and progesterone influence bovine sperm to 
assist in weakening the outer membranes and allowing accessibility of the male 
genome. In this study, the effects of both DTT and progesterone sperm treatments have 
been shown to positively influence fertilization rates in bovine ICSI, resulting in 
increased numbers of zygotes containing 2 pronuclei and no visible sperm head. 
However, zygotes injected with DTT treated sperm displayed significantly higher rates 
of abnormalities in DNA staining, consistent with DNA fragmentation. Such observations 
were not seen in zygotes injected with control, or progesterone treated sperm. This 
indicates that while both treatments lead to increased rates of fertilization, progesterone 
may be a better alternative for bovine ICSI. Further study is needed to assess 
fragmentation of injected zygotes and further optimization of progesterone treatment 
may be needed. However, this new protocol for bovine ICSI including the progesterone 
treatment of sperm has been demonstrated to increase fertilization rates. Utilizing the 
physiological processes of fertilization may be the key to successfully performing ICSI in 
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species where ICSI is not currently a viable or cost-effective option. As these processes 
of fertilization between sperm and oocyte are fairly ubiquitous between species, it is 
likely this new protocol can be adapted in other species or in situations where sperm 



























Prepare day of use, sterile filter (.2 µm) Equilibrate to 37°C and 5% CO2 before use.  
 
 








Prepare day of use, sterile filter (.2 µm) Equilibrate to 37°C before use.  
 
 
Component Source Amount/10 mL 
Sperm- TL Cassion IVL03 10 mL 
BSA Sigma 6003 0.03 g 
Sodium Pyruvate 100x  Sigma P4562 100 µL 
Pen/Strep 100x Sigma P4333 100 µL 
Component Source Amount/10 mL 
Hepes- TL Cassion IVL01 10 mL 
BSA Sigma 6003 0.03 g 
Sodium Pyruvate 100x  Sigma P4562 100 µL 









Aliquot into 100 µL, store -20°C, dilute with additional 200 µL hepes-TALP before use.  
 
 





Aliquot and keep in -20°C 1 month 
 
 









Component Source Amount/10 mL 
Hepes- TALP Cassion IVL01 10 mL 
Hyaluronidase Sigma H4272 3 mg 
Component Source Amount/5 mL 
Sperm- TL Cassion IVL03 5 mL 
Dithiothreitol Sigma D0632 0.0617 g 
Component Source Amount 
Sperm- TALP stock 1.5 mL 
DTT 10x stock stock 100 µL 
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Aliquot and keep -20°C away from light for 1 month 
 
 






Prepare day of use. For staining, add oocytes/embryos to solution for 15 minutes. Keep 
away from light.  
 
 





Filter (.2 µM) and aliquot. Store in -20°C 
 
 
Component Source Amount 
PBS (-ca, -mg) Gibco 14190144 2 mL 
Bisbenzimide Sigma 14533 0.002 g 
Component Source Amount 
PBS (-ca, -mg) Gibco 14190144 1 mL 
BSA Sigma 4503 0.03 g 
Hoechst 10x stock stock 10 µL 
Component Source Amount 
PBS (-ca, -mg) Gibco 14190144 10 mL 








Prepare day of use. Equilibrate at 37°C and 5%CO2  
 
 





Do not filter. Store 4°C away from light for 1 week 
 
 









Component Source Amount 
Sperm-TALP stock 10 mL 
Heparin 100x stock stock .100 µL 
Component Source Amount 
Progesterone Sigma P8783 0.0157 g 
Absolute ethanol Sigma E7023 5 mL 
Component Source Amount 
Progesterone Stock stock 1 µL 
Sperm-TALP stock 1 mL  
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Filter (.2 µm). Store -20°C away from light 
 
 

















Component Source Amount 
PBS (-ca, -mg) Gibco 14190144 4 mL 
Lectin from Arachis 
hypogaea 
Sigma L7381 2 mg 
Component Source Amount 
Sperm-TALP stock 1 mL 
FITC-PNA stock stock 10 µL 
Component Source Amount 
DMSO Sigma D8418 268 µL 
Ionomycin Sigma 10634 1 mg 
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Prepare day of use. Dilute further to working solution 
 





Prepare day of use. Equilibrate 37°C  
 










Prepare day of use. Equilibrate at 38.5°C at 5% CO2 before use. 
Component Source Amount 
Heaps-TALP stock 45 µL 
Ionomycin stock stock 5 µL 
Component Source Amount 
Hepes-TALP stock 990 mL 
Ionomycin step dilution stock 10 µL 
Component Source Amount 
SOF Cassion IVL05 9.4 mL 
Sodium Pyruvate 100x  Sigma P4562 100 µL 
Pen/Strep 100x Sigma P4333 100 µL 
BSA Sigma 6003 0.04 g 
BME 50x stock Sigma B6766 200 µL 









Heat to dissolve. Aliquot into 10 µL and store -20°C for 1 month. 
 














Component Source Amount 




Component Source Amount 
DMAP stock stock 10 µL 




Águila, L., R. Felmer, M. E. Arias, F. Navarrete, D. Martin-Hidalgo, H. C. Lee, P. 
Visconti, and R. Fissore. 2017. Defective sperm head decondensation 
undermines the success of ICSI in the bovine. Reproduction 154:307–318 
 
Arias, M.E., Sanchez R., Risopatron J., Perez L. and Felmer R. 2014. Effect of sperm 
pretreatment with sodium hydroxide and dithiothreitol on the efficiency of bovine 
intracytoplasmic sperm injection. Reproduction, Fertility and Development 26 
847–854. 
 
Arias, M.E., Sanchez-Villalba E., Delgado A. and Felmer R. 2017. Effect of transfection 
and co-incubation of bovine sperm with exogenous DNA on sperm quality and 
functional parameters for its use in sperm mediated gene transfer. Zygote 25 85–
97. 
 
Ashibe, S., R. Miyamoto, Y. Kato, and Y. Nagao. 2019. Detrimental effects of oxidative 
stress in bovine oocytes during intracytoplasmic sperm injection (ICSI). 
Theriogenology 133:71–78.  
 
Ates, B., B. C. Ercal, K. Manda, L. Abraham, and N. Ercal. 2009. Determination of 
glutathione disulfide levels in biological samples using thiol-disulfide exchanging 
agent, dithiothreitol. Biomedical Chromatography 23:119–123 
 
Braun, R. E. 2001. Packaging paternal chromosomes with protamine. Nature Genetics 
28:10–12. 
 
Calogero, A. E., N. Burrello, N. Barone, I. Palermo, U. Grasso, and R. Dagata. 2000. 
Effects of progesterone on sperm function: mechanisms of action. Human 
Reproduction 15:28–45. 
 
Canel, N., Bevacqua R., Fernandez-Martin R. and Salamone D.F. 2010. Activation with 
ionomycin followed by dehydroleucodine and cytochalasin B for the production of 




Canel, N.G., Bevacqua R.J., Hiriart M.I., Rabelo N.C., de Almeida Camargo L.S., 
Romanato M, de Calvo L.P. and Salamone D.F. 2017. Sperm pretreatment with 
heparin and L-glutathione, sex-sorting, and double cryopreservation to improve 
intracytoplasmic sperm injection in bovine. Theriogenology 93 62–70.  
 
Catt, J., and S. Rhodes. 1995. Comparative intracytoplasmic sperm injection (ICSI) in 
human and domestic species. Reproduction, Fertility and Development 7:161. 
 
Catt, S.L., Catt J.W., Gomez M.C., Maxwell W.M. and Evans G. 1996. Birth of a male 
lamb derived from an in vitro matured oocyte fertilized by intracytoplasmic 
injection of a single presumptive male sperm. Veterinary Record 16 494–495. 
 
Chang, M. C. 1959. Fertilization of Rabbit Ova in vitro. Nature 184:466–467. 
 
Cheng, F. P., A. Fazeli, W. F. Voorhout, A. Marks, M. M. Bevers, and B. Colenbrander. 
1996. Use of peanut agglutinin to assess the acrosomal status and the zona 
pellucida-induced acrosome reaction in stallion spermatozoa. Journal of 
Andrology 17:674–682. 
 
Chung, J.T., Keefer C.L. & Downey B.R. 2000. Activation of bovine oocytes following 
intracytoplasmic sperm injection (ICSI). Theriogenology 53 1273–1284. 
 
Cochran, R., Meintjes M., Reggio B., Hylan D., Carter J., Pinto C., Paccamonti D. and 
Godke R.A. 1998. Live foals produced from sperm-injected oocytes derived from 
pregnant mares. Journal of Equine Veterinary Science 18 736–740. 
 
Contreras, H. R., J. Roa, and M. A. Ramirez. 1999. Effect of Progesterone On 
Acrosome Reaction, Hypoosmotic Swelling Test, And Dna Stability In Human 
Spermatozoa. Archives of Andrology 42:97–104. 
 
Curnow, E. C., J. P. Ryan, D. M. Saunders, and E. S. Hayes. 2010. Developmental 
potential of bovine oocytes following IVM in the presence of glutathione ethyl 




De La Fuente, R. & King W.A. 1998. Developmental consequences of karyokinesis 
without cytokinesis during the first mitotic cell cycle of bovine parthenotes. 
Biology of Reproduction 58 952–962. 
 
Devito, L.G., Fernandes C.B., Blanco I.D.P., Tsuribe PM & LandimAlvarenga FC. 2010. 
Use of a piezo drill for intracytoplasmic sperm injection into cattle oocytes 
activated with ionomycin associated with roscovitine. Reproduction in Domestic 
Animals 45 654–658. 
 
Dozortsev, D., A. Rybouchkin, P. Sutter, C. Qian, and M. Dhont. 1995. Fertilization and 
early embryolgoy: Human oocyte activation following intracytoplasmic injection: 
the role of the sperm cell. Human Reproduction 10:403–407. 
 
Emelyanov, A. V., and D. V. Fyodorov. 2016. Thioredoxin-dependent disulfide bond 
reduction is required for protamine eviction from sperm chromatin. Genes & 
Development 30:2651–2656. 
 
Ferré, L. B., M. E. Kjelland, L. B. Strøbech, P. Hyttel, P. Mermillod, and P. J. Ross. 
2019. Review: Recent advances in bovine in vitro embryo production: 
reproductive biotechnology history and methods. animal:1–14. 
 
Galli, C., I. Vassiliev, I. Lagutina, A. Galli, and G. Lazzari. 2003. Bovine embryo 
development following ICSI: effect of activation, sperm capacitation and pre-
treatment with dithiothreitol. Theriogenology 60:1467–1480 
 
Gomez, M.C., Pope C.E., Harris R., Davis A., Mikota S. and Dresser B.L. 2000. Births 
of kittens produced by intracytoplasmic sperm injection of domestic cat oocytes 
matured in vitro. Reproduction, Fertility and Development 12 423–433. 
 
Gómez-Martínez, J. (2019) Sperm preparation and egg activation for bovine Intra-
Cytoplasmic Sperm Injection (ICSI). PhD thesis, University of Nottingham 
 
Goto, K., Kinoshita A., Takuma Y. and Ogawa K. 1990. Fertilization of bovine oocytes 




Hamano, K., Li X., Qian X.Q., Funauchi K., Furudate M. and Minato Y. 1999. Gender 
preselection in cattle with intracytoplasmically injected, flow cytometrically sorted 
sperm heads. Biology of Reproduction 60 1194–1197. 
 
Hewitson, L., Simerly C., Dominko T., Schatten G. 2000 Cellular and molecular events 
after in vitro fertilisation and intracytoplasmic sperm injection. Theriogenology 
53:95–104 
 
Horiuchi, T., and T. Numabe. 1999. Intracytoplasmic Sperm Injection (ICSI) in Cattle 
and Other Domestic Animals: Problems and Improvements in Practical Use. 
Journal of Mammalian Ova Research 16:1–9. 
 
Ho, H.C., K. A. Granish, and S. S. Suarez. 2002. Hyperactivated Motility of Bull Sperm 
Is Triggered at the Axoneme by Ca2 and Not cAMP. Developmental Biology 
250:208–217. 
 
Hosoi, Y. and Iritani A. 1993. Rabbit microfertilization. Molecular Reproduction and 
Development 36 282–284. 
 
Hutchison,, J. M., D. C. Rau, and J. E. Derouchey. 2017. Role of Disulfide Bonds on 
DNA Packaging Forces in Bull Sperm Chromatin. Biophysical Journal 113:1925–
1933. 
 
Jamil, K., and I. G. White. 1981. Induction of Acrosomal Reaction in Sperm with 
lonophore A23187 and Calcium. Archives of Andrology 7:283–292. 
 
Katayama, M., T. Miyano, M. Miyake, and S. Kato. 2002. Progesterone treatment of 
boar spermatozoa improves male pronuclear formation after intracytoplasmic 
sperm injection into porcine oocytes. Zygote 10:95–104. 
 
Kimura, Y and Yanagimachi R. 1995. Intracytoplasmic sperm injection in the mouse. 
Biology of Reproduction 52 709–720. 
 
Kolbe, T. and Holtz W. 2000. Birth of a piglet derived from an oocyte fertilized by 




Lee, J.W. and Yang X. 2004. Factors affecting fertilization of porcine oocytes following 
intracytoplasmic injection of sperm. Molecular Reproduction and Development 68 
96–102. 
 
Lee, J.W., H.C. Chang, H.Y. Wu, S.S. Liu, C.H. Wang, C.Y. Chu, and P.C. Shen. 2015. 
Effects of sperm pretreatment and embryo activation methods on the 
development of bovine embryos produced by intracytoplasmic sperm injection. 
Reproductive Biology 15:154–162. 
 
Li, G.P., G. Seidel, and E. Squires. 2003. Intracytoplasmic sperm injection of bovine 
oocytes with stallion spermatozoa. Theriogenology 59:1143–1155. 
 
Lishko, P. V., I. L. Botchkina, and Y. Kirichok. 2011. Progesterone activates the 
principal Ca2 channel of human sperm. Nature 471:387–391. 
 
Ma, H, Marti-Gutierrez, N-Park, Sw-Wu, J-Lee, Y-Suzuki, K-Koski ,A-Ji, D-Hayama, T-
Ahmed, R-Darby, H-Van, C-Li, Y-Kang, E-Park, Ar-Kim, D-Kim, St-Gong, J-Gu, 
Y-Xu, X-Battaglia, D-Krieg, Sa-Lee, Dm-Wu, Dh-Wolf ,Dp-Heitner, Sb-Belmonte, 
Jci-Amato, P-Kim, Js-Kaul, S-Mitalipov. 2017. Correction of a pathogenic gene 
mutation in human embryos. Nature:548. 413-419. 
 
Mclay, D., and H. Clarke. 2003. Remodelling the paternal chromatin at fertilization in 
mammals. Reproduction:625–633. 
 
Miller, M. R., N. Mannowetz, A. T. Iavarone, R. Safavi, E. O. Gracheva, J. F. Smith, R. 
Z. Hill, D. M. Bautista, Y. Kirichok, and P. V. Lishko. 2016. Unconventional 
endocannabinoid signaling governs sperm activation via the sex hormone 
progesterone. Science 352:555–559. 
 
Morozumi, K., Shikano T., Miyazaki S. and Yanagimachi R. 2006. Simultaneous 
removal of sperm plasma membrane and acrosome before intracytoplasmic 
sperm injection improves oocyte activation/embryonic development. PNAS:103 
17661–1766. 
 
Mortimer, D., E. F. Curtis, and R. G. Miller. 1987. Specific labelling by peanut agglutinin 




Nagy, S., J. Jansen, E. K. Topper, and B. M. Gadella. 2003. A Triple-Stain Flow 
Cytometric Method to Assess Plasma- and Acrosome-Membrane Integrity of 
Cryopreserved Bovine Sperm Immediately after Thawing in Presence of Egg-
Yolk Particles1. Biology of Reproduction 68:1828–1835 
 
Nakai, M., M. Ozawa, N. Maedomari, J. Noguchi, H. Kaneko, J. Ito, A. Onishi, N. 
Kashiwazaki, and K. Kikuchi. 2014. Delay in Cleavage of Porcine Embryos after 
Intracytoplasmic Sperm Injection (ICSI) Shows Poorer Embryonic Development. 
Journal of Reproduction and Development 60:256–259. 
 
Ock, S., J. Bhak, S. Balasubramanian, H. Lee, S. Choe, and G. Rho. 2003. Different 
activation treatments for successful development of bovine oocytes following 
intracytoplasmic sperm injection. Zygote 11:69–76. 
 
Oikawa, T, Itahashi T and Numabe T. 2016. Improved embryo development in 
Japanese black cattle by in vitro fertilization using ovum pick-up plus 
intracytoplasmic sperm injection with dithiothreitol. Journal of Reproduction and 
Development 62 11–16. 
 
Parinaud, J., B. Labal, and G. Vieitez. 1992. High progesterone concentrations induce 
acrosome reaction with a low cytotoxic effect. Fertility and Sterility 58:599–602 
 
Parrish, JJ, Susko-Parrish J, Winer MA, First NL. 1988. Capacitation of bovine sperm by 
heparin. Biol Reprod. 1171-80 
 
Perreault, S. D., R. R. Barbee, K. H. Elstein, R. M. Zucker, and C. L. Keefer. 1988. 
Interspecies Differences in the Stability of Mammalian Sperm Nuclei Assessed in 
Vivo by Sperm Microinjection and in Vitro by Flow Cytometry1. Biology of 
Reproduction 39:157–167. 
 
Pope, C.E., Johnson C.A., McRae M.A., Keller G.L. and Dresser B.L. 1998. 
Development of embryos produced by intracytoplasmic sperm injection of cat 
oocytes. Animal Reproduction Science 53 221–236. 
 
Rader K, Choi YH and Hinrichs K. 2016. Intracytoplasmic sperm injection, embryo 
culture, and transfer of in vitro-produced blastocysts Veterinary Clinics of North 
America: Equine Practice 32 401–413.  
61 
 
Rho G.J., S. Kawarsky, W. H. Johnson, K. Kochhar, and K. J. Betteridge. 1998. Sperm 
and Oocyte Treatments to Improve the Formation of Male and Female Pronuclei 
and Subsequent Development Following Intracytoplasmic Sperm Injection into 
Bovine Oocytes1. Biology of Reproduction 59:918–924. 
 
Romero-Aguirregomezcorta, J., S. Cronin, E. Donnellan, and S. Fair. 2019. 
Progesterone induces the release of bull spermatozoa from oviductal epithelial 
cells. Reproduction, Fertility and Development 31:1463. 
 
Ross. P.J., Beyhan Z., Iager A.E., Yoon S.Y., Malcuit C., Schellander K., Fissore R.A. & 
Cibelli J.B. 2008. Parthenogenetic activation of bovine oocytes using bovine and 
murine phospholipase C zeta. BMC Developmental Biology 8 16–28. 
 
Salamone, D. F., N. G. Canel, and M. B. Rodríguez. 2017. Intracytoplasmic sperm 
injection in domestic and wild mammals. Reproduction 154. 
 
Salisbury, G. W., Van Denmark, N.L. and Lodge, J.R.1978: Morphology and motility of 
spermatozoa. In: Physiology of Reproduction and Artificial Insemination of Cattle, 
pp.286-328, W.H Freeman & Co., San Francisco 
 
Sanches, B. V., A. F. Zangirolamo, N. C. Silva, F. Morotti, and M. M. Seneda. 2017. 
Cryopreservation of in vitro-produced embryos: challenges for commercial 
implementation. Animal Reproduction 14:521–527. 
 
Sekhavati, M.H., Shadanloo F., Hosseini M.S., Tahmoorespur M., Nasiri M.R., 
Hajian M. and Nasr-Esfahani M.H. 2012. Improved bovine ICSI outcomes by 
sperm selected after combined heparin-glutathione treatment. Cell Reprogram 14 
295–304. 
 
Simopoulou, M., Giannelou P., Bakas P., Gkoles L., Kalampokas T., Pantos K., and 
Koutsilieris M., 2016. Review: Making ICSI Safer and More Effective: A Review 
of the Human Oocyte and ICSI. In Vivo. 30(4): 387-400 
 
Sun, X.H., Y.Y. Zhu, L. Wang, H.L. Liu, Y. Ling, Z.L. Li, and L.B. Sun. 2017. The 
Catsper channel and its roles in male fertility: a systematic review. Reproductive 
Biology and Endocrinology 15 
62 
 
Sutovsky, P., R. Oko, L. Hewitson, and G. Schatten. 1997. The Removal of the Sperm 
Perinuclear Theca and Its Association with the Bovine Oocyte Surface during 
Fertilization. Developmental Biology 188:75–84. 
 
Suttirojpattana, T., Somfai T., Matoba S., Nagai T., Parnpai R. amd Geshi M. 2016. 
Pretreatment of bovine sperm with dithiobutylamine (DTBA) significantly 
improves embryo development after ICSI. Journal of Reproduction and 
Development 62 577–585. 
 
Suttner, R., V. Zakhartchenko, P. Stojkovic, S. Müller, R. Alberio, I. Medjugorac, G. 
Brem, E. Wolf, and M. Stojkovic. 2000. Intracytoplasmic sperm injection in 
bovine: Effects of oocyte activation, sperm pretreatment and injection technique. 
Theriogenology 54:935–948. 
 
Szczygiel, M. A., and W. S. Ward. 2002. Combination of Dithiothreitol and Detergent 
Treatment of Spermatozoa Causes Paternal Chromosomal Damage1. Biology of 
Reproduction 67:1532–1537. 
 
Tamburrino, L., S. Marchiani, F. Minetti, G. Forti, M. Muratori, and E. Baldi. 2014. The 
CatSper calcium channel in human sperm: relation with motility and involvement 
in progesterone-induced acrosome reaction. Human Reproduction 29:418–428. 
 
 
Tatham, B., A. Sathananthan, V. Dharmawardena, D. Munesinghe, I. Lewis, and A. 
Trounson. 1996. Fertilization and early embryology: Centrifugation of bovine 
oocytes for nuclear micromanipulation and sperm microinjection. Human 
Reproduction 11:1499–1503. 
 
Tesarik, J. 1998. Oocyte activation after intracytoplasmic injection of mature and 
immature sperm cells. Human Reproduction 13:117–127. 
 
Wang, B., Baldassarre H., Pierson J., Cote F., Rao K.M and Karatzas C.N. 2003. The in 
vitro and in vivo development of goat embryos produced by intracytoplasmic 




Yamauchi, Y., J. M. Riel, and M. A. Ward. 2011. Paternal DNA Damage Resulting From 
Various Sperm Treatments Persists After Fertilization and Is Similar Before and 
After DNA Replication. Journal of Andrology 33:229–238. 
 
Zambrano, F, Aguila L, Arias ME, Sanchez R & Felmer R. 2016. Improved 
preimplantation development of bovine ICSI embryos generated with 
spermatozoa pretreated with membrane-destabilizing agents lysolecithin and 
Triton X-100. Theriogenology 86 1489–1497. 
 
Zambrano, F, Aguila L, Arias M.E., Sanchez R and Felmer R. 2017. Effect of sperm 
pretreatment with glutathione and membrane destabilizing agents lysolecithin 
and Triton X-100, on the efficiency of bovine intracytoplasmic sperm injection. 
Reproduction in Domestic Animals 52 305–311. 
 
Zheng, J.F., X.B. Chen, L.W. Zhao, M.Z. Gao, J. Peng, X.Q. Qu, and H.J. Jin. 2015. 
ICSI treatment of severe male infertility can achieve prospective embryo quality 















Lauren Nicole Gatenby was born in Houston, Texas in August 1994. She 
attended Lawrence E. Elkins High School in Missouri City, Texas, where she graduated 
in June 2012. She then went on to pursue a B.S. in Animal Science from Louisiana 
State University in the College of Agriculture. While at LSU, Lauren worked in the lab of 
Dr. Kenneth Bondioli and obtained a grant for undergraduate research during her Junior 
year. Lauren graduated LSU in May 2017. Before she continued her education and 
research.   
Lauren began graduate school at Louisiana State University in 2017 under the 
tutelage of Dr. Kenneth Bondioli. She continued to study and research Reproductive 
Physiology and Embryo Biotechnology and collaborate on many projects. She is now a 
candidate for the degree of Master of Science, anticipating graduating August 2020, in 
Reproductive Physiology from the School of Animal Sciences at Louisiana State 
University, Baton Rouge, Louisiana.  
 
 
 
 
 
 
 
